These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2735944)

  • 1. 6-Hydroxydopamine toxicity to dopamine neurons in culture: potentiation by the addition of superoxide dismutase and N-acetylcysteine.
    Mytilineou C; Danias P
    Biochem Pharmacol; 1989 Jun; 38(11):1872-5. PubMed ID: 2735944
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.
    Michel PP; Hefti F
    J Neurosci Res; 1990 Aug; 26(4):428-35. PubMed ID: 1977925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic aspects of the interaction of ascorbic acid with alloxan and 6-hydroxydopamine.
    Heikkila RE; Cohen G
    Ann N Y Acad Sci; 1975 Sep; 258():221-30. PubMed ID: 1060403
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro.
    Graham DG; Tiffany SM; Bell WR; Gutknecht WF
    Mol Pharmacol; 1978 Jul; 14(4):644-53. PubMed ID: 567274
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 6-hydroxydopamine on polymerization of tubulin. Protection by superoxide dismutase, catalase, or anaerobic conditions.
    Davison AJ; Legault NA; Steele DW
    Biochem Pharmacol; 1986 May; 35(9):1411-7. PubMed ID: 3085678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nomifensine on the toxicity of 6-hydroxydopamine for mesotelencephalic dopamine neurons.
    Lees GJ; Kydd RR; Horsburgh RJ; Wright JJ
    Brain Res; 1984 Aug; 308(1):155-8. PubMed ID: 6434148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of superoxide dismutase and catalase on catalysis of 6-hydroxydopamine and 6-aminodopamine autoxidation by iron and ascorbate.
    Sullivan SG; Stern A
    Biochem Pharmacol; 1981 Aug; 30(16):2279-85. PubMed ID: 6794574
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of synergistic toxicity of the radioprotective agent, WR2721, and 6-hydroxydopamine.
    Schor NF
    Biochem Pharmacol; 1988 May; 37(9):1751-62. PubMed ID: 2897858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemiluminescence from 6-hydroxydopamine: involvement of hydrogen peroxide, the superoxide radical and the hydroxyl radical, a potential role for singlet oxygen.
    Heikkila RE; Cabbat FS
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):649-62. PubMed ID: 197576
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation.
    Monteiro HP; Winterbourn CC
    Biochem Pharmacol; 1989 Dec; 38(23):4177-82. PubMed ID: 2512934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of amygdaloid kindling and metrazol-induced seizures by 6-hydroxydopamine in rats.
    Corcoran ME; Fibiger HC; McCaughran JA; Wada JA
    Exp Neurol; 1974 Oct; 45(1):118-33. PubMed ID: 4153438
    [No Abstract]   [Full Text] [Related]  

  • 12. The apparent inhibition of superoxide dismutase activity by quinones.
    Butler J; Hoey BM
    J Free Radic Biol Med; 1986; 2(1):77-81. PubMed ID: 3772043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.
    Muñoz AM; Rey P; Soto-Otero R; Guerra MJ; Labandeira-Garcia JL
    J Neurosci Res; 2004 May; 76(4):551-62. PubMed ID: 15114627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate.
    Heikkila RE; Cohen G
    Science; 1973 Aug; 181(4098):456-7. PubMed ID: 4718113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxy-radical toxicity in catecholamine neurons.
    Cohen G
    Neurotoxicology; 1984; 5(1):77-82. PubMed ID: 6326007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture.
    Wentzel P; Thunberg L; Eriksson UJ
    Diabetologia; 1997 Jan; 40(1):7-14. PubMed ID: 9028712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
    Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro bacterial model of cytotoxicity to living cells caused by dopamine and 6-hydroxydopamine oxidation at physiological pH.
    Giunta S; Galeazzi L; Groppa G
    Free Radic Biol Med; 1991; 10(5):297-303. PubMed ID: 1906828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nickel on oxygen free radical metabolism. Inhibition of superoxide dismutase and enhancement of hydroxydopamine autoxidation.
    Shainkin-Kestenbaum R; Caruso C; Berlyne GM
    Biol Trace Elem Res; 1991 Mar; 28(3):213-21. PubMed ID: 1713044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Human Superoxide Dismutase and
    Kopincova J; Kolomaznik M; Mikolka P; Kosutova P; Topercerova J; Matasova K; Calkovska A; Mokra D
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30841517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.